Exploring the Serum Level of RE1 Silencing Transcription Factor in Alzheimer's Disease

Objectives The aim of this study was to evaluate the serum RE1 silencing transcription factor (REST) level in Alzheimer's disease (AD), mild cognitive impairment (MCI), and elderly controls by using surface plasmon resonance (SPR) technology. Materials and Methods In this case–contro...

Full description

Bibliographic Details
Main Authors: Shashank Shekhar, Manjari Tripathi, A.B. Dey, Sharmistha Dey
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-01-01
Series:Annals of the National Academy of Medical Sciences (India)
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731970